Revolutionizing IBD research with on-chip models of disease modeling and drug screening.
Options
Description
Eylul Gulsen Yilmaz, Nedim Hacıosmanoğlu and, Sebastian Bruno Ulrich Jordi are Co-first authors.
BORIS DOI
Publisher DOI
PubMed ID
39523166
Description
Inflammatory bowel disease (IBD) comprises chronic inflammatory conditions with complex mechanisms and diverse manifestations, posing significant clinical challenges. Traditional animal models and ethical concerns in human studies necessitate innovative approaches. This review provides an overview of human intestinal architecture in health and inflammation, emphasizing the role of microfluidics and on-chip technologies in IBD research. These technologies allow precise manipulation of cellular and microbial interactions in a physiologically relevant context, simulating the intestinal ecosystem microscopically. By integrating cellular components and replicating 3D tissue architecture, they offer promising models for studying host-microbe interactions, wound healing, and therapeutic approaches. Continuous refinement of these technologies promises to advance IBD understanding and therapy development, inspiring further innovation and cross-disciplinary collaboration.
Date of Publication
2025-05
Publication Type
Article
Subject(s)
Keyword(s)
inflammatory bowel disease
•
microfluidics
•
on-a-chip
•
wound healing
Language(s)
en
Contributor(s)
Yilmaz, Eylul Gulsen | |
Hacıosmanoğlu, Nedim | |
Inci, Fatih |
Series
Trends in Biotechnology
Publisher
Cell Press
ISSN
1879-3096
0167-7799
Access(Rights)
restricted